DR. DANIEL M IBACH MD NPI 1619947876

NPI Details

DR. Daniel M Ibach, MD is a hematology and oncology internal medicine in Knoxville, TN with 32 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Daniel M Ibach, MD NPI is 1619947876. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:1994

The provider's business location address is:

9957 SHERRILL BLVD
KNOXVILLE, TN
ZIP 37932-366
Phone: (865) 693-2255
Fax: (865) 691-7888

The NPI 1619947876 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Iron level (HCPCS:83540)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Folic acid level, serum (HCPCS:82746)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Protein measurement, serum (HCPCS:84165)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Urinalysis, manual test (HCPCS:81002)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection of drug or substance into vein (HCPCS:96374)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Red blood count, automated test (HCPCS:85045)
• Erythropoietin (protein) level (HCPCS:82668)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Collection of blood sample from implanted device (HCPCS:36591)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Drawing of blood for a medical problem (HCPCS:99195)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Haptoglobin (serum protein) level (HCPCS:83010)

The enumeration date for this NPI number is 1/23/2006 and was last updated on 3/2/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.